TREAT AND MAINTAIN Trademark

Trademark Overview


On Saturday, March 12, 2022, a trademark application was filed for TREAT AND MAINTAIN with the United States Patent and Trademark Office. The USPTO has given the TREAT AND MAINTAIN trademark a serial number of 97309325. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Thursday, June 15, 2023. This trademark is owned by EyePoint Pharmaceuticals US, Inc.. The TREAT AND MAINTAIN trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Drug delivery agents consisting of polymer compounds that facilitate the delivery of pharmaceuticals for the treatment of ocular diseases and conditions, namely, age-related macular degeneration, diabetic retinopathy, diabetic macular edema, retinal vein occlusion and retinal disease; pharmaceutical preparations for the treatment of ocular diseases and conditions, namely, age-related macular degeneration, diabetic retinopathy, diabetic macular edema, retinal vein occlusion and retinal disease

Sustained drug delivery systems for ocular drugs
treat and maintain

General Information


Serial Number97309325
Word MarkTREAT AND MAINTAIN
Filing DateSaturday, March 12, 2022
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateThursday, June 15, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesDrug delivery agents consisting of polymer compounds that facilitate the delivery of pharmaceuticals for the treatment of ocular diseases and conditions, namely, age-related macular degeneration, diabetic retinopathy, diabetic macular edema, retinal vein occlusion and retinal disease; pharmaceutical preparations for the treatment of ocular diseases and conditions, namely, age-related macular degeneration, diabetic retinopathy, diabetic macular edema, retinal vein occlusion and retinal disease
Goods and ServicesSustained drug delivery systems for ocular drugs

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, March 17, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateThursday, March 17, 2022
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEyePoint Pharmaceuticals US, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWatertown, MA 02472

Trademark Events


Event DateEvent Description
Thursday, June 15, 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Thursday, June 15, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Thursday, June 15, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Thursday, December 1, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, December 1, 2022NON-FINAL ACTION E-MAILED
Thursday, December 1, 2022NON-FINAL ACTION WRITTEN
Thursday, December 1, 2022ASSIGNED TO EXAMINER
Thursday, March 17, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, March 16, 2022NEW APPLICATION ENTERED